Anna Yang, PharmD, is a Clinical Innovation and Technology Leader in the US Medical Affairs Innovation Hub at Genentech. Anna partners with study teams on all US-based efforts in the decentralized clinical trial (DCT) space and helps drives innovation across the Genentech portfolio. Anna also sits on the Decentralized Trials and Research Alliance for DCT Key Performance Indicators/Metrics team and is a member of the Veterans Affairs Industry Partner Consortium. Anna received her PharmD at the Rutgers Ernest Mario School of Pharmacy and completed a postdoctoral fellowship in the Genentech BioOncology Medical Science Liaisons team.